Like0000000or copy the linkRick Doblin, Ph.D., Founder and Executive Director of the Multidisciplinary Association for Psychedelic Studies (MAPS), explores how potential FDA, EMA, and global regulatory approval of MDMA-assisted therapy for PTSD may contribute to [More]
Like0000000or copy the linkBad trips, anti-drug PSAs, and the crackdown under the Controlled Substances Act of 1970 helped stigmatize psychedelics in the U.S. But now, there’s renewed clinical inquiry into whether these drugs can ease [More]
Like0000000or copy the linkAs the state begins to roll out proposed rules that will eventually regulate the psychedelic therapy industry, 9NEWS got an inside look at a magic mushroom session. Read more: https://www.9news.com/article/news/an-inside-look-at-what-happens-during-a-psychedelic-therapy-session-in-colorado/73-99ecf0c1-f7ec-4da7-a0f2-1153b499534e More local [More]
Like0000000or copy the linkPsychedelic-assisted therapy is changing the landscape of our field and as more clients experience profound breakthroughs with this unique form of treatment, demand only continues to grow, leaving many scrambling to find [More]
Like0000000or copy the linkThis is a presentation recorded at the 2023 joint conference of the Society for Economic Botany and Society of Ethnobiology, held at Emory University in Atlanta, Georgia from June 4-9, 2023. #ethnobotany [More]
Like0000000or copy the linkJosh Woolley, M.D., Ph.D., associate professor of psychology at UC San Francisco (@ucsf), discusses the topic “Researching Psilocybin Therapy: Current Challenges and Future Prospects.” The lecture was recorded March 23, 2023, at [More]